Concepedia

Viralkumar Patel

VP

Statistics

Publications

7

Citations

469

H-Index

7

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Viralkumar Patel is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and apoptosis.

ORCID

Publications per year

1991–2017

7

Publications

7

Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells

Viralkumar Patel, Kumudha Balakrishnan, Mary Ayres et al. · Clinical Cancer Research · 2016 · 146 citations · Full text

, , +14

Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.

Sundeep Khosla, Viralkumar Patel, Ian Hay et al. · Journal of Clinical Investigation · 1991 · 140 citations · Full text

, , +17

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)

Viralkumar Patel, Kumudha Balakrishnan, Mark Douglas et al. · Leukemia · 2016 · 67 citations · Full text

, , +6

Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy

Viralkumar Patel, Betty Lamothe, Mary Ayres et al. · Leukemia · 2017 · 45 citations · Full text

, , +13

Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells

Viralkumar Patel, Kumudha Balakrishnan, Michael J. Keating et al. · Blood · 2014 · 32 citations · Full text

, , +14

1–5 of 7